Invesco’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Invesco’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-73	Closed	-$5K	–	4163
2015 Q2	$5K	Buy	+73	New	+$3.38K	﹤0.01%	4252

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Invesco's ANTH Position: Q3 2015 in Review

Invesco sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2015, closing a stake of 73 shares — an estimated $5K sold.

Invesco first reported a position in ANTH in Q2 2015 and held it in 1 quarter. The position peaked at $5K in Q2 2015. 86 funds tracked by Wall St. Rank hold ANTH as of Q3 2015.

Invesco reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Invesco sold 73 Anthera Pharmaceuticals, Inc. shares in Q3 2015, an estimated $5K.
Invesco first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
Invesco's Anthera Pharmaceuticals, Inc. position peaked at $5K in Q2 2015.
86 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2015.

Based on Invesco's 13F filing for Q3 2015, filed 16 Nov 2015.